Cargando…
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543833/ https://www.ncbi.nlm.nih.gov/pubmed/37773132 http://dx.doi.org/10.1186/s13045-023-01503-8 |
| _version_ | 1785114369926889472 |
|---|---|
| author | Cai, Letong Li, Yuchen Tan, Jiaxiong Xu, Ling Li, Yangqiu |
| author_facet | Cai, Letong Li, Yuchen Tan, Jiaxiong Xu, Ling Li, Yangqiu |
| author_sort | Cai, Letong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10543833 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105438332023-10-03 Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy Cai, Letong Li, Yuchen Tan, Jiaxiong Xu, Ling Li, Yangqiu J Hematol Oncol Correction BioMed Central 2023-09-29 /pmc/articles/PMC10543833/ /pubmed/37773132 http://dx.doi.org/10.1186/s13045-023-01503-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Cai, Letong Li, Yuchen Tan, Jiaxiong Xu, Ling Li, Yangqiu Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy |
| title | Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy |
| title_full | Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy |
| title_fullStr | Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy |
| title_full_unstemmed | Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy |
| title_short | Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy |
| title_sort | correction: targeting lag-3, tim-3, and tigit for cancer immunotherapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543833/ https://www.ncbi.nlm.nih.gov/pubmed/37773132 http://dx.doi.org/10.1186/s13045-023-01503-8 |
| work_keys_str_mv | AT cailetong correctiontargetinglag3tim3andtigitforcancerimmunotherapy AT liyuchen correctiontargetinglag3tim3andtigitforcancerimmunotherapy AT tanjiaxiong correctiontargetinglag3tim3andtigitforcancerimmunotherapy AT xuling correctiontargetinglag3tim3andtigitforcancerimmunotherapy AT liyangqiu correctiontargetinglag3tim3andtigitforcancerimmunotherapy |